1. Adelaide Research & Scholarship

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 41 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsiesMd Dom, Z.; Noll, B.; Coller, J.; Somogyi, A.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2013Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2011Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methodsSallustio, B.; Noll, B.; Morris, R.
2004Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7Toutsikos, P.; Miners, J.; Stapleton, A.; Thomas, A.; Sallustio, B.; Knights, K.
1995Biosynthesis, characterisation and direct high-performance liquid chromatographic analysis of gemfibrozil 1-O-β-acylglucuronideSallustio, B.; Fairchild, B.
2005Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasmaWestley, I.; Sallustio, B.; Morris, R.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2005The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemiaDavies, B.; Coller, J.; James, H.; Somogyi, A.; Horowitz, J.; Sallustio, B.
2007Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaInglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
1999Some international approaches to aminoglycoside monitoring in the extended dosing interval eraMorris, R.; Sallustio, B.; Vinks, A.; LeGatt, D.; Verjee, Z.; Desoky, E.

Discover